MiR-1a-3p/Fcgr4-dependent osteoclast activation regulates pathological bone loss - Summary - MDSpire

MiR-1a-3p/Fcgr4-dependent osteoclast activation regulates pathological bone loss

  • By

  • Jiayao Zhang

  • Yun Zhai

  • Liang He

  • Yunping Song

  • Mingxuan Lu

  • Xuerui Xiang

  • Jiehong Huang

  • Jinyin Huang

  • Weiqing Tian

  • Yue Zhao

  • Shuxian Lin

  • Weicai Liu

  • May 25, 2026

  • 0 min

Share

Objective:

To investigate the role of the miR-1a-3p–Fcgr4 axis in immune-mediated osteoclast dysregulation and its contribution to pathological bone loss.

Key Findings:
  • Fcgr4 is a direct target of miR-1a-3p.
  • Overexpression of miR-1a-3p significantly suppresses osteoclast activity.
  • miR-1a-3p expression is reduced in human osteoporosis cohorts and animal models of bone loss.
  • In the CUMS model, decreased miR-1a-3p expression correlates with increased Fcgr4 expression and enhanced osteoclast activity.
Interpretation:

Limitations:
  • The study primarily focuses on the miR-1a-3p–Fcgr4 interaction without exploring other potential regulatory pathways.
  • The implications of these findings in human clinical settings remain to be fully established.
Conclusion:

Original Source(s)

Related Content